ACUTE AND CHRONIC EFFECTS OF BOTULINUM NEUROTOXIN A ON THE MAMMALIAN NEUROMUSCULAR JUNCTION

被引:9
|
作者
Baskaran, Padmamalini [1 ]
Thyagarajan, Baskaran [1 ,2 ]
机构
[1] Univ Wyoming, Sch Pharm, Laramie, WY 82071 USA
[2] Univ Wyoming, Program Neurosci, Laramie, WY 82071 USA
基金
美国国家卫生研究院;
关键词
acetylcholine release; botulinum neurotoxin; end plate currents; SNAP-25; spontaneous release; twitch tension; TOXIN TYPE-A; TRANSMITTER RELEASE; NEUROTRANSMITTER RELEASE; INTRACELLULAR CA2+; VESICLE DOCKING; PROTEIN SNAP-25; IN-VITRO; RAT; 3,4-DIAMINOPYRIDINE; MEMBRANE;
D O I
10.1002/mus.24119
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Botulinum neurotoxin A (BoNT/A) cleaves SNAP-25 and inhibits acetylcholine (ACh) release at the neuromuscular junctions (NMJ) to cause neuroparalysis. Previous reports indicate a dyssynchrony between the inhibitory effect of BoNT/A on ACh release and SNAP-25 cleavage. Methods: We tested the in vitro (acute; 90 min) and in vivo (chronic; 12 h) effects of BoNT/A on stimulus-evoked ACh release (SEAR), twitch tension, and SNAP-25 cleavage in isolated extensor digitorum longus (EDL) nerve-muscle preparations (NMP). Results: In vitro or in vivo BoNT/A poisoning inhibited SEAR and twitch tension. Conversely, SNAP-25 cleavage and inhibition of spontaneous release frequency were observed only in NMP poisoned with BoNT/A in vivo. Moreover, chronic treatment of BoNT/A inhibited ionomycin stimulated Ca2+ signals in Neuro 2a cells. Conclusions: These results demonstrate that the inhibition of SEAR precedes SNAP-25 cleavage and suggest involvement of a more complex mechanism for the inhibitory effect of BoNT/A at the NMJ.
引用
收藏
页码:206 / 215
页数:10
相关论文
共 50 条
  • [1] Molecular targets of botulinum toxin at the mammalian neuromuscular junction
    Coffield, J
    Kalandakanond, S
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R16 - R16
  • [2] Molecular targets of botulinum toxin at the mammalian neuromuscular junction
    Whelchel, DD
    Breluner, TM
    Brooks, PM
    Coffield, JA
    MOVEMENT DISORDERS, 2004, 19 : S7 - S16
  • [3] CHRONIC DENERVATION CAUSED BY BOTULINUM NEUROTOXIN AS A MODEL OF A NEUROMUSCULAR DISEASE
    FRANGEZ, R
    DOLINSEK, J
    DEMSAR, F
    SUPUT, D
    TOXINS AND EXOCYTOSIS, 1994, 710 : 88 - 93
  • [4] COMPARISON OF THE EFFECTS OF BOTULINUM NEUROTOXIN TYPE-A AND TYPE-E AT THE RAT NEUROMUSCULAR-JUNCTION
    SELLIN, LC
    KAUFFMAN, JA
    DASGUPTA, BR
    MEDICAL BIOLOGY, 1983, 61 (02): : 120 - 125
  • [5] Perturbation to Cholesterol at the Neuromuscular Junction Confers Botulinum Neurotoxin A Sensitivity to Neonatal Mice
    Thyagarajan, Baskaran
    Potian, Joseph G.
    McArdle, Joseph J.
    Baskaran, Padmamalini
    TOXICOLOGICAL SCIENCES, 2017, 159 (01) : 179 - 188
  • [6] NEUROMUSCULAR EFFECTS DISTANT FROM THE SITE OF BOTULINUM NEUROTOXIN INJECTION
    OLNEY, RK
    AMINOFF, MJ
    GELB, DJ
    LOWENSTEIN, DH
    NEUROLOGY, 1988, 38 (11) : 1780 - 1783
  • [7] Botulinum Neurotoxin Type A is Internalized and Translocated from Small Synaptic Vesicles at the Neuromuscular Junction
    Cesare Colasante
    Ornella Rossetto
    Laura Morbiato
    Marco Pirazzini
    Jordi Molgó
    Cesare Montecucco
    Molecular Neurobiology, 2013, 48 : 120 - 127
  • [8] INTERACTION BETWEEN BOTULINUM NEUROTOXIN AND BETA-BUNGAROTOXIN AT THE RAT NEUROMUSCULAR-JUNCTION
    DOLLY, JO
    GWILT, M
    TSE, CK
    WRAY, D
    JOURNAL OF PHYSIOLOGY-LONDON, 1981, 317 (AUG): : P91 - P92
  • [9] CHARACTERIZATION OF THE ACTIONS OF BOTULINUM NEUROTOXIN TYPE-E AT THE RAT NEUROMUSCULAR-JUNCTION
    MOLGO, J
    DASGUPTA, BR
    THESLEFF, S
    ACTA PHYSIOLOGICA SCANDINAVICA, 1989, 137 (04): : 497 - 501
  • [10] Botulinum Neurotoxin Type A is Internalized and Translocated from Small Synaptic Vesicles at the Neuromuscular Junction
    Colasante, Cesare
    Rossetto, Ornella
    Morbiato, Laura
    Pirazzini, Marco
    Molgo, Jordi
    Montecucco, Cesare
    MOLECULAR NEUROBIOLOGY, 2013, 48 (01) : 120 - 127